Chronic Granulomatous Disease Study in China

Status Not yet recruiting

Clinical Trial Summary

CGD is a rare inherited primary immunodeficiency which is caused by the defect in one of the subunits of NADPH oxidase complex.We tend to collect and analyze Chinese CGD patients who are diagnosed in hospitals affiliated to Shanghai Jiao Tong University School of Medicine, including clinical feature, laboratory data and genetic information. we aim to find out clinical, distribution, genetic characteristic of CGD in Chinese population, etc., thus further improving the level of diagnosis and treatment for CGD.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02231996
Study type	Observational [Patient Registry]
Source	Shanghai Children's Medical Center
Contact	jing wu
Email	wujingecnu@163.com
Status	Not yet recruiting
Phase	N/A
Start date	September 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00010361` - Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders	N/A
Enrolling by invitation	`NCT02082353` - Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Active, not recruiting	`NCT00564759` - Gene Therapy for Chronic Granulomatous Disease	Phase 1/Phase 2
Recruiting	`NCT00001405` - Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
Completed	`NCT00033982` - Posaconazole to Treat Invasive Fungal Infections	Phase 3